PMID- 22519948 OWN - NLM STAT- MEDLINE DCOM- 20121031 LR - 20161125 IS - 1502-7708 (Electronic) IS - 0036-5521 (Linking) VI - 47 IP - 7 DP - 2012 Jul TI - A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease. PG - 836-41 LID - 10.3109/00365521.2012.677955 [doi] AB - BACKGROUND: Type 2 diabetes mellitus (T2DM) is a major risk factor for the development of non-alcoholic fatty liver disease (NAFLD) and subsequently hepatic fibrosis. Transient elastography (TE) is a rapid, reproducible non-invasive test that may be appropriate as a screening tool for the presence of hepatic fibrosis. AIM: Assess the utility of TE as a screening tool for the presence of hepatic fibrosis in a T2DM population with no known liver disease. METHODS: T2DM patients without known liver disease were included. Patients were assessed with TE in addition to biochemical parameters. RESULTS: A successful TE evaluation could be obtained in 74 of 81 (91%) included subjects. Of these, 26 (35%) had a liver stiffness measurement (LSM) >/= 7.65 kPa. Sixteen of these subjects had confirmatory liver biopsies with significant (>/= F2 fibrosis) present in 12 (75%) and cirrhosis diagnosed in 2 subjects. 15/16 (94%) had histological steatohepatitis. Compared with those with a lower LSM, subjects with an LSM >/= 7.65 kPa had higher ALT levels (38.0 +/- 21.7 vs 26.1 +/- 11.1 U/L, p = 0.021) and increased prevalence of hepatic steatosis by ultrasound (85% vs 63%, p = 0.005). CONCLUSION: Significant hepatic fibrosis in the T2DM population is frequently under-recognized. TE may be a feasible tool for the screening of T2DM patients for the presence of hepatic fibrosis. FAU - Casey, Stephen P AU - Casey SP AD - Departments of Gastroenterology, Alfred Hospital, Melbourne, Vic, Australia. FAU - Kemp, William W AU - Kemp WW FAU - McLean, Catriona A AU - McLean CA FAU - Topliss, Duncan J AU - Topliss DJ FAU - Adams, Leon A AU - Adams LA FAU - Roberts, Stuart K AU - Roberts SK LA - eng PT - Clinical Trial PT - Comparative Study PT - Journal Article DEP - 20120423 PL - England TA - Scand J Gastroenterol JT - Scandinavian journal of gastroenterology JID - 0060105 RN - EC 2.6.1.2 (Alanine Transaminase) SB - IM MH - Aged MH - Alanine Transaminase/blood MH - Algorithms MH - Biopsy MH - Body Mass Index MH - Chi-Square Distribution MH - Decision Support Techniques MH - Diabetes Mellitus, Type 2/*complications MH - *Elasticity Imaging Techniques MH - Fatty Liver/classification/complications/*diagnostic imaging MH - Female MH - Humans MH - Liver Cirrhosis/blood/complications/*diagnosis MH - Male MH - Mass Screening MH - Middle Aged MH - Predictive Value of Tests MH - Statistics, Nonparametric MH - Waist Circumference EDAT- 2012/04/24 06:00 MHDA- 2012/11/01 06:00 CRDT- 2012/04/24 06:00 PHST- 2012/04/24 06:00 [entrez] PHST- 2012/04/24 06:00 [pubmed] PHST- 2012/11/01 06:00 [medline] AID - 10.3109/00365521.2012.677955 [doi] PST - ppublish SO - Scand J Gastroenterol. 2012 Jul;47(7):836-41. doi: 10.3109/00365521.2012.677955. Epub 2012 Apr 23.